United States, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) -- Demand for osteoporosis therapeutics is anticipated to increase at a CAGR of 2.9% from 2022 to 2026, as per this new analysis by Fact.MR, a market research and competitive intelligence provider. The osteoporosis therapeutics market is projected to surge to a valuation of US$ 14.2 Bn by the end of 2026. The demand for Osteoporosis Therapeutics is expected to rise over the forecast period and the market is projected to gain a global market size worth of US$ 10.01 Bn by the end of 2022.
Browse in-depth TOC on "Demand of Osteoporosis Therapeutics Market"
32 Tables, 123 Figures and 188 Pages
Osteoporosis is a medical condition that weakens the bones and makes them brittle. This condition is highly prevalent in old people, and since the aging population is increasing across the world at a significant pace, this will be a prime driver for market expansion. Increasing sedentary lifestyle, poor eating habits, and rising awareness of osteoporosis are other factors that will guide osteoporosis therapeutics market growth through the coming years.
For Critical Insights on North America Osteoporosis Therapeutics Market, Request a Sample Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7285
However, lack of diagnosis of osteoporosis and longer time taken by regulatory authorities to approve osteoporosis drugs are expected to constrain osteoporosis therapeutics market potential through 2026. Osteoporosis drug manufacturers are focusing on launching new drugs and commercializing them to ensure maximum market penetration.
In April 2022, Pfenex Inc., a biotechnology company, announced the commercialization of the Teriparatide Injection by its commercialization partner Alvogen in the United States. This will be used for postmenopausal women suffering from osteoporosis and other applications as well.
Which Regional Markets Should Osteoporosis Therapeutic Drug Suppliers Focus On?
“North America Expected to Account for Highest Osteoporosis Therapeutics Demand”
The North America osteoporosis therapeutics market is anticipated to have a bright outlook over the coming years and will hold a dominant market share in the global landscape.
Increasing sedentary lifestyles, rising instances of osteoporosis, the presence of developed healthcare infrastructure, and high healthcare spending potential are expected to be major factors influencing shipments of osteoporosis drugs through 2026.
The Europe osteoporosis therapeutics market is expected to hold a significant market share in the global landscape throughout the forecast period. Increasing spending on research and development activities are expected to prominently influence osteoporosis therapeutics market potential in this region.
South Asia and East Asia are predicted to provide lucrative opportunities for osteoporosis therapeutics market players. Rising awareness of osteoporosis, increasing healthcare expenditure, and the growing aging population in the aforementioned regions are expected to majorly influence osteoporosis therapeutics market growth.
Malaysia, India, and China are anticipated to be rewarding markets for osteoporosis drug suppliers.
To learn more about Latin America Osteoporosis Therapeutics Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7285
Key Segments Covered in the Osteoporosis Therapeutics Industry Survey
- Osteoporosis Therapeutics Market by Drug Class:
- Bisphosphonates
- Selective Estrogen Inhibitor Modulators (SERM)
- Parathyroid Hormone Therapies
- Calcitonin
- Rank Ligand Inhibitors
- Osteoporosis Therapeutics Market by Route of Administration:
- Oral Osteoporosis Therapeutics
- Injectable Osteoporosis Therapeutics
- Other Routes of Administration
Competitive Landscape
Osteoporosis drug manufacturers are increasing their investments in the research and development of novel drugs to fast-track new launches. Osteoporosis treatment injections are gaining popularity and market players are trying to launch these to advance their revenue potential in the global market.
- In October 2021, Entera Bio, a leading biotechnology company, posted crucial data for its oral osteoporosis drug formulation trial that is in its mid-stage. The company moved ahead to phase 3 registration of this study.
Get Customization on East Asia Osteoporosis Therapeutics Market Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7108
Key players in the Osteoporosis Therapeutics Market-
- Allergan Plc.
- Amgen Inc.
- Chugai Pharmaceutical
- Daiichi Sankyo Co. Ltd.
- Egalet Corporation
- Eisai Co. Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
Key Takeaways from South Asia & Oceania Osteoporosis Therapeutics Market Study
- In 2022, the global osteoporosis therapeutics market stands at a net value of US$ 12.7 Bn.
- The osteoporosis therapeutics market is projected to expand at a CAGR of 2.9% from 2022 to 2026, and reach US$ 14.2 Bn by the end of 2026.
- Increasing aging population and rising prevalence of osteoporosis are major factors driving market growth.
- Longer approval times and lack of diagnostic equipment are expected to hamper osteoporosis therapeutics market potential to some extent through 2026.
- In 2022, the U.S. osteoporosis therapeutics market accounts for around 41% of the global market share.
- The market for osteoporosis therapeutics in China is predicted to rise at a CAGR of 5.4% from 2022 to 2026.
Explore Fact.MR’s Coverage on the Healthcare Domain -
Antiseptic and Disinfectant Market Analysis- Despite mounting worries regarding organisms' increasing disinfectant tolerance, the antiseptic and disinfectant business is developing at a faster-than-average rate. Antiseptics and disinfectants are now available in a variety of formulations, including sprays, ointments, wipes, gels, and liquids, making them more convenient to use for end users.
Dental Infection Control Products Market Forecast - The global dental infection control products market is expanding rapidly, owing to increased demand for dental care products. This increase in demand is due to an increase in the incidence of oral diseases, a growing geriatric population with cavity issues, and changing lifestyles and eating habits.
Dental Consumables Market Size- The dental consumables market is expected to rise steadily through 2030, driven by rising cases of tooth problems and demand for invasive dental procedures. Increased dental tourism in developing nations like China and India, as well as an increasing senior population, are all contributing to this trend.
Dental Restoratives Market Growth - Dental care requirements have resulted in a considerable shift in the type of dental care services, from traditional restorative to cosmetic and preventive. Generic factors, such as rising dental difficulties among the elderly, developing dental tourism, and an increase in the number of certified practitioners, are expected to boost the dental restoratives market.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
Japan Sales Office
4-1-1 Nakano,
9F Nakano Sunplaza
Tokyo, 164-8512
Japan
E: sales@factmr.com
